Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523368 Target Snapshot

Prolyl 4-hydroxylase · SINGLE PROTEIN · Paramecium bursaria Chlorella virus 1

52Compounds
13Assays
3Approved Drugs
35.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q84406. Use UniProt Q84406 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q84406 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Prolyl 4-hydroxylase as ChEMBL target CHEMBL4523368, mapped to UniProt Q84406. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Prolyl 4-hydroxylase
SINGLE PROTEIN · Paramecium bursaria Chlorella virus 1
As of 2026-09-13
ChEMBL target ID
CHEMBL4523368
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q84406
Prolyl 4-hydroxylase
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Prolyl 4-hydroxylase is the right protein anchor across sources, using UniProt Q84406 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProlyl 4-hydroxylase
UniProt AccessionQ84406
Component TypeProtein
Sequence Length242 aa

Prolyl 4-hydroxylase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Prolyl 4-hydroxylase, mapped to UniProt Q84406. Sequence length is 242 aa.

Mapped IDQ84406
Review nameProlyl 4-hydroxylase
OrganismParamecium bursaria Chlorella virus 1
Clinical Profile

Clinical Phase Distribution

3
Approved
2
Phase II
Assay Mix

Activity Type Distribution

IC5028.0
KI7.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3646221 6.55 Ki 280.0 Approved
CHEMBL426560 6.15 Ki 710.0 Preclinical
CHEMBL2338329 5.97 Ki 1070.0 Approved
CHEMBL3646117 5.6 IC50 2500.0 Preclinical
CHEMBL316034 5.48 Ki 3280.0 Preclinical
CHEMBL426560 5.35 IC50 4500.0 Preclinical
CHEMBL2338329 5.3 IC50 5000.0 Approved
CHEMBL316034 5.28 IC50 5300.0 Preclinical
CHEMBL4163812 5.12 Ki 7650.0 Preclinical
CHEMBL3186774 5.07 IC50 8500.0 Preclinical
Distribution

pChEMBL Value Distribution

6
5.0
2
5.5
1
6.0
1
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

VADADUSTAT
CHEMBL3646221
Approved 2023
Assay Landscape

Assay Landscape

13
Total Assays
14
Tested Compounds
1
Assay Types
Binding — 13 assays, 14 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 13 14 5.2

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine